Correspondence on editorial regarding "Atezolizumab and bevacizumab for hepatocellular carcinoma: how to approach salvage therapy for non-responders?"

Chon, Young Eun; Kim, Dong Yun; Chon, Hong Jae; Kim, Do Young

Chon, Young Eun; Kim, Dong Yun; Chon, Hong Jae; Kim, Do Young.

Afiliación

Chon YE; Department of Gastroenterology, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea.
Kim DY; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
Chon HJ; Department of Medical Oncology, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea.
Kim DY; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.

Clin Mol Hepatol ; 2024 May 30.

Article en En | MEDLINE | ID: mdl-38816178

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Mol Hepatol Año: 2024 Tipo del documento: Article Pais de publicación: Corea del Sur

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google